Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...
The team created a novel cell lineage-tracing model to reveal where the virus hides, and developed genetic profiles of T ...
One dose of the Jynneos vaccine was 58% effective against mpox infection overall and 84% in people without HIV, but only 35% ...
Researchers from Imperial College London, working with the University of Oxford and Rockefeller University, have shown ...
A vaccine's ability to generate long-lasting, high-affinity antibodies hinges on a delicate balance. Upon exposure to a ...
This research on a T-cell–targeting vaccine in HIV has implications for future study design to incorporate consideration of ...
Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The ...
A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people ...
EnnoDC presents positive Phase I data at CROI 2025, demonstrating long-lasting immunity induced by Antibody Mediated Vaccines (AMVs)Findings in ...
News-Medical.Net on MSN11d
Gaps in HPV cancer screening and prevention identified for people living with HIVA new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people living with HIV and outlines future research priorities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback